About Michael
Michael H. Bison: Experienced Biotechnology and Life Sciences Attorney in Boston, Massachusetts, United States
Michael H. Bison is a partner in Goodwin's nationally and internationally recognized Technology and Life Sciences practice group and a member of its Life Sciences and Capital Markets practices. He represents privately held and publicly traded companies with a strong emphasis on companies across the spectrum of the life sciences industry, including biotechnology, medical devices, diagnostics and healthcare information technology.
Practice Areas
- Biotechnology and Life Sciences Practice
- Venture Capital Law
Awards
- Recognized: Biotechnology and Life Sciences Practice, Recognized: Venture Capital Law, Practice Area: Mergers and Acquisitions Law, Practice Area: Securities / Capital Markets Law
Mr. Bison is regularly recognized by his clients for his extensive industry knowledge and for providing practical, result-oriented legal advice.
Education & Credentials
- Firms: Goodwin
- Affiliations: Inclusion of professional affiliations here if any (e.g., American Bar Association)
- Languages: Not provided in the details, so not included
- Recognized Since: Recognized in Best Attorney USA since 2019
Mrs. Bison's work has been recognized by several industry publications, including the Best Lawyers in America, LMG Life Sciences, Who’s Who Legal, The Legal 500, Law & Politics magazine, and Boston Magazine.
Professional Philosophy and Approach to Cases
Mr. Bison believes in treating each client with the utmost professionalism and respect, understanding that every case is unique and requires a tailored approach. He works closely with management teams and boards of directors throughout the company's life cycle, providing practical and result-oriented legal advice.
He has advised numerous international companies on their U.S. listings, capital markets transactions, strategic collaborations and M&A transactions, as well as the establishment of U.S. subsidiaries and various operational matters with respect to these subsidiaries.
